Literature DB >> 12629382

Determinants of long-term sexual health outcome after radical prostatectomy measured by a validated instrument.

Brent K Hollenbeck1, Rodney L Dunn, John T Wei, James E Montie, Martin G Sanda.   

Abstract

PURPOSE: We combined the strengths of previous patient reported studies (that is use of a validated instrument) with the assets of previous single surgeon, physician reported series (that is prospective collection of operative data) by performing a multiple surgeon study to identify demographic and operative determinants of post-prostatectomy sexual health related quality of life outcomes.
MATERIALS AND METHODS: Sexual outcome was measured after prostatectomy in 671 prostate cancer cases with a followup of 4 to 52 months treated by any of 7 urologists at a high volume medical center and 112 age matched controls by cross-sectional health related quality of life assessment using the Expanded Prostate Cancer Index Composite validated questionnaire. Multivariable ANCOVA was done to identify the baseline determinants affecting post-prostatectomy sexual health outcomes among 17 clinical and demographic factors.
RESULTS: Factors independently associated with better sexual health outcome in patients included younger age (p <0.0001), nerve sparing technique (p <0.0001), time since prostatectomy (p = 0.0001), smaller prostate size (p = 0.003), higher education level (p = 0.02), and higher household income (p = 0.02). Orgasm was achieved at a higher rate than erection. In controls only age (p = 0.0004) and having a partner (p = 0.04) were significantly associated with sexual health.
CONCLUSIONS: Larger prostate size adversely affected sexual health outcome after radical prostatectomy independent of all other measured factors. Patient sexual outcome did not differ significantly among surgeons who performed a broad range of such procedures yearly, suggesting that surgical expertise cannot be measured simply by the number of such operations that a surgeon performs. Stratifying patient reported sexual function by the principal determinants of age, nerve sparing and prostate size provides a basis for counseling patients.

Entities:  

Mesh:

Year:  2003        PMID: 12629382     DOI: 10.1097/01.ju.0000056737.40872.56

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  19 in total

1.  Prediction of erectile function following treatment for prostate cancer.

Authors:  Mehrdad Alemozaffar; Meredith M Regan; Matthew R Cooperberg; John T Wei; Jeff M Michalski; Howard M Sandler; Larry Hembroff; Natalia Sadetsky; Christopher S Saigal; Mark S Litwin; Eric Klein; Adam S Kibel; Daniel A Hamstra; Louis L Pisters; Deborah A Kuban; Irving D Kaplan; David P Wood; Jay Ciezki; Rodney L Dunn; Peter R Carroll; Martin G Sanda
Journal:  JAMA       Date:  2011-09-21       Impact factor: 56.272

2.  Social Support and Health-Related Quality of Life Among Gay and Bisexual Men With Prostate Cancer.

Authors:  Benjamin D Capistrant; Lindsey Lesher; Nidhi Kohli; Enyinnaya N Merengwa; Badrinath Konety; Darryl Mitteldorf; William G West; B R Simon Rosser
Journal:  Oncol Nurs Forum       Date:  2018-07-02       Impact factor: 2.172

3.  [Sexuality of couples 5 years after radical prostatectomy. Sexuality of patients and their partners 1 year postoperatively in sexually active couples].

Authors:  T B Jordan; R Ernst; G Hatzichristodoulou; A Dinkel; T Klorek; C Beyrle; J E Gschwend; K Herkommer
Journal:  Urologe A       Date:  2015-10       Impact factor: 0.639

4.  Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.

Authors:  Daniel A Barocas; JoAnn Alvarez; Matthew J Resnick; Tatsuki Koyama; Karen E Hoffman; Mark D Tyson; Ralph Conwill; Dan McCollum; Matthew R Cooperberg; Michael Goodman; Sheldon Greenfield; Ann S Hamilton; Mia Hashibe; Sherrie H Kaplan; Lisa E Paddock; Antoinette M Stroup; Xiao-Cheng Wu; David F Penson
Journal:  JAMA       Date:  2017-03-21       Impact factor: 56.272

5.  Does robotic technology mitigate the challenges of large prostate size?

Authors:  Ted A Skolarus; Ryan C Hedgepeth; Yun Zhang; Alon Z Weizer; Jeffrey S Montgomery; David C Miller; David P Wood; Brent K Hollenbeck
Journal:  Urology       Date:  2010-08-13       Impact factor: 2.649

6.  Complementary and alternative medicine use, patient-reported outcomes, and treatment satisfaction among men with localized prostate cancer.

Authors:  Scott D Ramsey; Steven B Zeliadt; David K Blough; Catherine R Fedorenko; Megan E Fairweather; Cara L McDermott; David F Penson; Stephen K Van Den Eeden; Ann S Hamilton; Neeraj K Arora
Journal:  Urology       Date:  2012-05       Impact factor: 2.649

7.  Caution with Use of the EPIC-50 Urinary Bother Scale: How Voiding Dysfunction Modifies its Performance.

Authors:  Lin Yang; Adam S Kibel; Graham A Colditz; Ratna Pakpahan; Kellie R Imm; Sonya Izadi; Robert L Grubb; Kathleen Y Wolin; Siobhan Sutcliffe
Journal:  J Urol       Date:  2017-07-18       Impact factor: 7.450

Review 8.  What happened? Sexual consequences of prostate cancer and its treatment.

Authors:  Anne Katz
Journal:  Can Fam Physician       Date:  2005-07       Impact factor: 3.275

Review 9.  The top 13: what family physicians should know about prostate cancer.

Authors:  Anne Katz; Alan Katz
Journal:  Can Fam Physician       Date:  2008-02       Impact factor: 3.275

10.  A systematic review of the correlates and management of nonpremature ejaculatory dysfunction in heterosexual men.

Authors:  Raouf Seyam
Journal:  Ther Adv Urol       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.